Health & Medicine : Science World Report

Mar 19, 2012 01:32 PM EDT

Step Forward in Research into New Treatments for Brain Edema

Cerebral edemas are accumulations of fluid into the intra- or extracellular spaces of the brain and it can result from several factors such as stroke or head trauma, among others.

Mar 19, 2012 01:04 PM EDT

Researchers Discover Novel Therapy for Crohn's Disease

The Nutritional Immunology and Molecular Medicine Laboratory (NIMML) research team at Virginia Tech has discovered important new information on the efficacy of conjugated linoleic acid (CLA) in treating Crohn's disease, a form of inflammatory bowel disease (IBD). CLA is a naturally occurring acid fo...

Mar 19, 2012 12:04 PM EDT

Solving the Mystery of Blood Clotting

How and when our blood clots is one of those incredibly complex and important processes in our body that we rarely think about. If your blood doesn't clot and you cut yourself, you could bleed to death, if your blood clots too much, you could be in line for a heart attack or stroke. Dr. Hans Vogel, ...

Mar 19, 2012 10:43 AM EDT

Study Shows Air Emissions near Fracking Sites May Impact Health

In a new study, researchers from the Colorado School of Public Health have shown that air pollution caused by hydraulic fracturing or fracking may contribute to acute and chronic health problems for those living near natural gas drilling sites.

Mar 19, 2012 10:17 AM EDT

Scientists Develop a Software Tool for Estimating Heart Disease Risk

University of Granada researchers have developed a software tool that makes an accurate estimation of the risk that a person has to suffer a heart disease. In addition, this software tool allows the performance of massive risk estimations, i.e. it helps estimating the risk that a specific population...

Mar 19, 2012 09:42 AM EDT

New Insight into Mechanisms behind Autoimmune Diseases Suggests a Potential Therapy

Autoimmune diseases, such as Type I diabetes and rheumatoid arthritis, are caused by an immune system gone haywire, where the body's defense system assaults and destroys healthy tissues. A mutant form of a protein called LYP has been implicated in multiple autoimmune diseases, but the precise molecu...

Mar 19, 2012 09:30 AM EDT

Bone Marrow Transplant Arrests Symptoms in Model of Rett Syndrome

A paper published online today in Nature describes the results of using bone marrow transplant (BMT) to replace faulty immune system cells in models of Rett Syndrome. The procedure arrested many severe symptoms of the childhood disorder, including abnormal breathing and movement, and significantly e...

Mar 18, 2012 02:57 PM EDT

Obesity Raises Death Risk Tied to Sleeping Pills

Obesity appears to significantly increase the risk of death tied to sleeping pills, nearly doubling the rate of mortality even among those prescribed 18 or fewer pills in a year, researchers reported Friday.

Mar 18, 2012 01:23 PM EDT

Cheap Generics no Panacea for India's Poorest

Cheap generic drugs were meant to change the life of Nandakhu Nissar, whose mouth is swollen by a cancerous tumor. But the cashless and hungry 55-year-old sleeps on a pavement staring up at the windows of Mumbai's biggest cancer hospital.

Mar 17, 2012 09:15 AM EDT

QB3, Pfizer Expand Support for Translational Research

The California Institute for Quantitative Biosciences (QB3) has renewed and expanded a three-year agreement with Pfizer Inc. to collaborate on research projects at the University of California with the potential to transform world-class science into better medicine.

Mar 17, 2012 08:56 AM EDT

Closing Hole in the Heart no Better than Drugs in Preventing Strokes

Loyola University Medical Center is one of the major enrollers in a landmark clinical trial that found that plugging a hole in the heart works no better than drugs in preventing strokes.

Mar 16, 2012 04:54 PM EDT

Response Rate High for Some Patients with metastatic Melanoma Treated with Vemurafenib

An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously...